pentaerythritol tetranitrate has been researched along with Gestational Hypertension in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodowski, L; Condic, M; de Vries, L; Delius, M; Eckmann-Scholz, C; Friebe-Hoffmann, U; Groten, T; Hoopmann, M; Hübener, C; Jäger, Y; Kagan, KO; Komar, M; Kraft, K; Lato, K; Lehmann, T; Pecks, U; Schlembach, D; Schleußner, E; Schrey-Petersen, S; Seeger, S; Seliger, G; Sroka, D; Städtler, M; Strizek, B; Tauscher, A; Verlohren, S; von Kaisenberg, CS; Winkler, JL | 1 |
1 trial(s) available for pentaerythritol tetranitrate and Gestational Hypertension
| Article | Year |
|---|---|
Effect of pentaerythritol tetranitrate (PETN) on the development of fetal growth restriction in pregnancies with impaired uteroplacental perfusion at midgestation-a randomized trial.
Topics: Female; Fetal Growth Retardation; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn; Pentaerythritol Tetranitrate; Perfusion; Perinatal Death; Placenta; Placentation; Pregnancy; Premature Birth | 2023 |